LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...
TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...
Will the FDA ever allow Ranbaxy Laboratories to sell a generic version of the Nexium heartburn pill? The Connecticut attorney general wants to know what is taking the agency so long, because Ranbaxy ...
The FDA approved the first generic version of Nexium — esomeprazole magnesium delayed-release capsules — to treat gastroesophageal reflux disease. Esomeprazole is a proton pump inhibitor that reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results